Why Aegis Capital Loves Adamas...And How To Bet On Parkinson's Treatment

By: via Benzinga
The share price of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) has risen a little over 13 percent year-to-date. Aegis ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.